Sort   by:  
 Page size 
UnknownClinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Not available
S-EPMC5455706 | biostudies-literature
UnknownWhite matter alterations over the course of two consecutive high-school football seasons and the effect of a jugular compression collar: A preliminary longitudinal diffusion tensor imaging study.
Not available
S-EPMC6866267 | biostudies-literature
UnknownFeasibility of Implementing Patient Priorities Care for Older Adults with Multiple Chronic Conditions.
Not available
S-EPMC7015118 | biostudies-literature
ProteomicsSchizophrenia Proteome Data High Resolution Method
PTM-tolerant quantitative proteome analysis of plasma collected from schizophrenia patients and nonspychiatric healthy controls.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-03-02 | MSV000086977 | MassIVE
MetabolomicsGNPS - Schizophrenia Plasma Metabolome Analysis
Metabolomics analysis of plasma collected from patients with schizophrenia and non-psychiatric control subjects.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-03-02 | MSV000086975 | GNPS
UnknownTrends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium.
Not available
S-EPMC10914672 | biostudies-literature
UnknownChanges in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.
Not available
S-EPMC8166576 | biostudies-literature
ProteomicsSchizophrenia Plasma Metabolome Analysis
Metabolomics analysis of plasma collected from patients with schizophrenia and non-psychiatric control subjects.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-03-02 | MSV000086975 | MassIVE
UnknownMycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Not available
S-EPMC5014629 | biostudies-literature
UnknownShort-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
Not available
S-EPMC6311344 | biostudies-literature
Sort   by:  
 Page size